Participants 0 119 4
Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
Participants 279 354 5
Patients diagnosed with bone metastases < or = 6 weeks prior to first visit
Participants 843 865 5
312 patients enrolled,
